162 related articles for article (PubMed ID: 12839838)
1. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.
Sotgia F; Woodman SE; Bonuccelli G; Capozza F; Minetti C; Scherer PE; Lisanti MP
Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1150-60. PubMed ID: 12839838
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic variability associated with Arg26Gln mutation in caveolin3.
Fee DB; So YT; Barraza C; Figueroa KP; Pulst SM
Muscle Nerve; 2004 Sep; 30(3):375-8. PubMed ID: 15318349
[TBL] [Abstract][Full Text] [Related]
4. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP
J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975
[TBL] [Abstract][Full Text] [Related]
5. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene.
Figarella-Branger D; Pouget J; Bernard R; Krahn M; Fernandez C; Lévy N; Pellissier JF
Neurology; 2003 Aug; 61(4):562-4. PubMed ID: 12939441
[TBL] [Abstract][Full Text] [Related]
6. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
Sotgia F; Bonuccelli G; Minetti C; Woodman SE; Capozza F; Kemp RG; Scherer PE; Lisanti MP
Am J Pathol; 2003 Dec; 163(6):2619-34. PubMed ID: 14633633
[TBL] [Abstract][Full Text] [Related]
7. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
8. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
Woodman SE; Sotgia F; Galbiati F; Minetti C; Lisanti MP
Neurology; 2004 Feb; 62(4):538-43. PubMed ID: 14981167
[TBL] [Abstract][Full Text] [Related]
9. A CAV3 microdeletion differentially affects skeletal muscle and myocardium.
Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP
Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034
[TBL] [Abstract][Full Text] [Related]
10. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.
Betz RC; Schoser BG; Kasper D; Ricker K; Ramírez A; Stein V; Torbergsen T; Lee YA; Nöthen MM; Wienker TF; Malin JP; Propping P; Reis A; Mortier W; Jentsch TJ; Vorgerd M; Kubisch C
Nat Genet; 2001 Jul; 28(3):218-9. PubMed ID: 11431690
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro.
Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C
Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147
[TBL] [Abstract][Full Text] [Related]
12. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy.
Tateyama M; Aoki M; Nishino I; Hayashi YK; Sekiguchi S; Shiga Y; Takahashi T; Onodera Y; Haginoya K; Kobayashi K; Iinuma K; Nonaka I; Arahata K; Itoyama Y
Neurology; 2002 Jan; 58(2):323-5. PubMed ID: 11805270
[TBL] [Abstract][Full Text] [Related]
13. Two novel CAV3 gene mutations in Japanese families.
Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I
Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037
[TBL] [Abstract][Full Text] [Related]
14. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
Kubisch C; Schoser BG; von Düring M; Betz RC; Goebel HH; Zahn S; Ehrbrecht A; Aasly J; Schroers A; Popovic N; Lochmüller H; Schröder JM; Brüning T; Malin JP; Fricke B; Meinck HM; Torbergsen T; Engels H; Voss B; Vorgerd M
Ann Neurol; 2003 Apr; 53(4):512-20. PubMed ID: 12666119
[TBL] [Abstract][Full Text] [Related]
15. Caveolae and caveolin-3 in muscular dystrophy.
Galbiati F; Razani B; Lisanti MP
Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
[TBL] [Abstract][Full Text] [Related]
16. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia.
Carbone I; Bruno C; Sotgia F; Bado M; Broda P; Masetti E; Panella A; Zara F; Bricarelli FD; Cordone G; Lisanti MP; Minetti C
Neurology; 2000 Mar; 54(6):1373-6. PubMed ID: 10746614
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy.
Hayashi T; Arimura T; Ueda K; Shibata H; Hohda S; Takahashi M; Hori H; Koga Y; Oka N; Imaizumi T; Yasunami M; Kimura A
Biochem Biophys Res Commun; 2004 Jan; 313(1):178-84. PubMed ID: 14672715
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling.
Brauers E; Dreier A; Roos A; Wormland B; Weis J; Krüttgen A
Am J Pathol; 2010 Jul; 177(1):261-70. PubMed ID: 20472890
[TBL] [Abstract][Full Text] [Related]
20. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
Volonte D; Peoples AJ; Galbiati F
Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
